IFNG and neoplasm: PD-1 antibody significantly increased the level of IFN-γ, granzyme-B, and a proliferation marker of T-cell that is Ki-67; the CAR-T cell combined with anti PD-1 showed significantly higher anti-tumor response compared to only CAR-T cells and isotype control antibody (123).